320 related articles for article (PubMed ID: 23526775)
1. Latest developments in molecular docking: 2010-2011 in review.
Yuriev E; Ramsland PA
J Mol Recognit; 2013 May; 26(5):215-39. PubMed ID: 23526775
[TBL] [Abstract][Full Text] [Related]
2. Improvements, trends, and new ideas in molecular docking: 2012-2013 in review.
Yuriev E; Holien J; Ramsland PA
J Mol Recognit; 2015 Oct; 28(10):581-604. PubMed ID: 25808539
[TBL] [Abstract][Full Text] [Related]
3. Challenges and advances in computational docking: 2009 in review.
Yuriev E; Agostino M; Ramsland PA
J Mol Recognit; 2011; 24(2):149-64. PubMed ID: 21360606
[TBL] [Abstract][Full Text] [Related]
4. Application of Monte Carlo-based receptor ensemble docking to virtual screening for GPCR ligands.
Vilar S; Costanzi S
Methods Enzymol; 2013; 522():263-78. PubMed ID: 23374190
[TBL] [Abstract][Full Text] [Related]
5. Protein flexibility in ligand docking and virtual screening to protein kinases.
Cavasotto CN; Abagyan RA
J Mol Biol; 2004 Mar; 337(1):209-25. PubMed ID: 15001363
[TBL] [Abstract][Full Text] [Related]
6. Molecular recognition and docking algorithms.
Brooijmans N; Kuntz ID
Annu Rev Biophys Biomol Struct; 2003; 32():335-73. PubMed ID: 12574069
[TBL] [Abstract][Full Text] [Related]
7. Importance of molecular computer modeling in anticancer drug development.
Geromichalos GD
J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
[TBL] [Abstract][Full Text] [Related]
8. Understanding the challenges of protein flexibility in drug design.
Antunes DA; Devaurs D; Kavraki LE
Expert Opin Drug Discov; 2015 Dec; 10(12):1301-13. PubMed ID: 26414598
[TBL] [Abstract][Full Text] [Related]
9. A detailed comparison of current docking and scoring methods on systems of pharmaceutical relevance.
Perola E; Walters WP; Charifson PS
Proteins; 2004 Aug; 56(2):235-49. PubMed ID: 15211508
[TBL] [Abstract][Full Text] [Related]
10. A critical assessment of docking programs and scoring functions.
Warren GL; Andrews CW; Capelli AM; Clarke B; LaLonde J; Lambert MH; Lindvall M; Nevins N; Semus SF; Senger S; Tedesco G; Wall ID; Woolven JM; Peishoff CE; Head MS
J Med Chem; 2006 Oct; 49(20):5912-31. PubMed ID: 17004707
[TBL] [Abstract][Full Text] [Related]
11. Use of the FACTS solvation model for protein-ligand docking calculations. Application to EADock.
Zoete V; Grosdidier A; Cuendet M; Michielin O
J Mol Recognit; 2010; 23(5):457-61. PubMed ID: 20101644
[TBL] [Abstract][Full Text] [Related]
12. Molecular flexibility in ab initio drug docking to DNA: binding-site and binding-mode transitions in all-atom Monte Carlo simulations.
Rohs R; Bloch I; Sklenar H; Shakked Z
Nucleic Acids Res; 2005; 33(22):7048-57. PubMed ID: 16352865
[TBL] [Abstract][Full Text] [Related]
13. Use of experimental design to optimize docking performance: the case of LiGenDock, the docking module of LiGen, a new de novo design program.
Beato C; Beccari AR; Cavazzoni C; Lorenzi S; Costantino G
J Chem Inf Model; 2013 Jun; 53(6):1503-17. PubMed ID: 23590204
[TBL] [Abstract][Full Text] [Related]
14. Computational approach to de novo discovery of fragment binding for novel protein states.
Konteatis ZD; Klon AE; Zou J; Meshkat S
Methods Enzymol; 2011; 493():357-80. PubMed ID: 21371598
[TBL] [Abstract][Full Text] [Related]
15. Ligand-guided receptor optimization.
Katritch V; Rueda M; Abagyan R
Methods Mol Biol; 2012; 857():189-205. PubMed ID: 22323222
[TBL] [Abstract][Full Text] [Related]
16. Docking and scoring in virtual screening for drug discovery: methods and applications.
Kitchen DB; Decornez H; Furr JR; Bajorath J
Nat Rev Drug Discov; 2004 Nov; 3(11):935-49. PubMed ID: 15520816
[TBL] [Abstract][Full Text] [Related]
17. Improved lead-finding for kinase targets using high-throughput docking.
McInnes C
Curr Opin Drug Discov Devel; 2006 May; 9(3):339-47. PubMed ID: 16729730
[TBL] [Abstract][Full Text] [Related]
18. Automated docking for novel drug discovery.
Bello M; MartÃnez-Archundia M; Correa-Basurto J
Expert Opin Drug Discov; 2013 Jul; 8(7):821-34. PubMed ID: 23642085
[TBL] [Abstract][Full Text] [Related]
19. FlexE: efficient molecular docking considering protein structure variations.
Claussen H; Buning C; Rarey M; Lengauer T
J Mol Biol; 2001 Apr; 308(2):377-95. PubMed ID: 11327774
[TBL] [Abstract][Full Text] [Related]
20. Lead optimization via high-throughput molecular docking.
Joseph-McCarthy D; Baber JC; Feyfant E; Thompson DC; Humblet C
Curr Opin Drug Discov Devel; 2007 May; 10(3):264-74. PubMed ID: 17554852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
